Bramble Bio is a premier cell-therapy Contract Development & Manufacturing Organisation (CDMO) offering end-to-end solutions for advanced therapy medicinal products (ATMPs). Leveraging more than two decades of expertise through its heritage in the FamiCord Group, Bramble Bio brings together a network of 15 laboratories across Europe,—underpinned by dual GMP-certified facilities—to support innovation from early development through commercial manufacture.

Its core services span process development and optimisation, tech-transfer, full cGMP manufacturing, analytical development (including potency and advanced assays), cell and tissue sourcing, and global logistics of cryopreserved materials.

By integrating sourcing of primary cells/tissues with manufacturing and distribution, Bramble Bio delivers a seamless “therapeutic journey” for cell-therapy innovators.

With more than 20 GMP clean-rooms and a track record supporting over 7,000 patients treated with CDMO-manufactured products, Bramble Bio is positioned as a trusted partner for biotech companies advancing into late-stage and commercial cell-therapy production.

The organisation differentiates itself through its regulatory-ready infrastructure, deep experience in perinatal and other complex tissue sourcing, and a materials-management and logistics network capable of worldwide delivery. It emphasises quality systems, regulatory compliance and manufacturing scalability, enabling clients to accelerate translational timelines and mitigate risk.

In short: Bramble Bio is a cell-therapy manufacturing partner built for speed, scale and regulatory rigour—empowering next-generation therapies to reach patients globally.

Company (Headquarters):

Poland

CDMO Services:

Drug Substance Manufacturing (API);Drug Product/FDF;Research & Development;Regulatory Services;Analytical Development;Supply Chain Logistics

Therapeutic Area:

Cardiovascular;Central Nervous System;Dermatology;Diagnostics and Monitoring;Digital Health;Ear Nose Throat and Oral health;Endocrine and Hormonal;Gastrointestinal and Metabolism;Genito Urinary and Women's Health;Hematology;Immunology;Infectious Disease;Medical Devices;Musculoskeletal System;Nutritional;Oncology;Ophthalmology;Platform Technologies;Radiopharmaceuticals;Rare and Genetic Disorders;Respiratory;Wounds and Injuries;Pain Symptoms

High Potent Products capabilities:

OEB 3 Medium Potency;OEB 4-5 Highly Potent APIs (HPAPIs)

Facilities Location:

Europe

Manufacturing Technologies:

Blow-Fill-Seal (BFS);Cartridges;Pre-Filled Syringes (PFS);Sterile Vials